| Mr Carl B Lebuhn, MD | |
|
1903 Broadway, Paducah, KY 42001-7105 | |
| (270) 444-9889 | |
| (270) 444-9291 |
| Full Name | Mr Carl B Lebuhn |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 34 Years |
| Location | 1903 Broadway, Paducah, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700880309 | NPI | - | NPPES |
| 000000282523 | Other | KY | ANTHEM BCBS |
| 35911 | Other | KY | KY LICENSE |
| 64026107 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 35911 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Paducah | Paducah, KY | Hospital |
| Lourdes Hospital | Paducah, KY | Hospital |
| Marshall County Hospital | Benton, KY | Hospital |
| Murray-calloway County Hospital | Murray, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heartland Cares, Inc | 0244206712 | 3 |
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
GlycoMimetics, Inc., a clinical stage biotechnology company developing a new class of glycobiology based therapies for a broad range of indications, today announced that the journal Blood has published pre-clinical data on the company's lead compound GMI-1070 in a model of sickle cell disease.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.
› Verified 9 days ago
| Entity Name | Heartland Cares, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396749917 PECOS PAC ID: 0244206712 Enrollment ID: O20040907000438 |
News Archive
GlycoMimetics, Inc., a clinical stage biotechnology company developing a new class of glycobiology based therapies for a broad range of indications, today announced that the journal Blood has published pre-clinical data on the company's lead compound GMI-1070 in a model of sickle cell disease.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.
› Verified 9 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
GlycoMimetics, Inc., a clinical stage biotechnology company developing a new class of glycobiology based therapies for a broad range of indications, today announced that the journal Blood has published pre-clinical data on the company's lead compound GMI-1070 in a model of sickle cell disease.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Carl B Lebuhn, MD 1903 Broadway, Paducah, KY 42001-7105 Ph: (270) 444-9889 | Mr Carl B Lebuhn, MD 1903 Broadway, Paducah, KY 42001-7105 Ph: (270) 444-9889 |
News Archive
GlycoMimetics, Inc., a clinical stage biotechnology company developing a new class of glycobiology based therapies for a broad range of indications, today announced that the journal Blood has published pre-clinical data on the company's lead compound GMI-1070 in a model of sickle cell disease.
"World Bank President Robert Zoellick on Thursday warned of rising food inflation and high oil prices resulting from political turmoil in the Middle East as risks to world growth, as they threaten to push more people into poverty," the Wall Street Journal's "Dispatch" blog reports.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.
› Verified 9 days ago
Mr. Danny Neale Butler, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2603 Kentucky Avenue, Suite 303, Paducah, KY 42003 Phone: 270-443-2900 Fax: 270-443-7122 | |
Winston Chua, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2603 Kentucky Ave, Suite 403, Paducah, KY 42003 Phone: 270-444-3930 Fax: 270-442-5284 | |
Lingaiah Chandrashekar, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 225 Medical Center Dr Ste 308, Paducah, KY 42003 Phone: 270-443-0777 Fax: 270-443-0999 | |
Gary Bodnarchuk, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1532 Lone Oak Rd, Suite 310, Paducah, KY 42003 Phone: 270-443-0777 Fax: 270-443-0999 | |
Dr. Bradley B Mcelroy, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2601 Kentucky Ave, Suite 301, Paducah, KY 42003 Phone: 270-575-3113 Fax: 270-575-3135 | |
Benjamin Howard Thompson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2501 Kentucky Ave, Paducah, KY 42003 Phone: 270-575-8472 | |
Joseph A Bassi Ii, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3131 Parisa Dr, Paducah, KY 42003 Phone: 270-444-8000 Fax: 270-444-8302 |